| MiR-7 in cancer development P Korać, M Antica, M Matulić Biomedicines 9 (3), 325, 2021 | 42 | 2021 |
| Role of MYC in B cell lymphomagenesis P Korać, S Dotlić, M Matulić, M Zajc Petranović, M Dominis Genes 8 (4), 115, 2017 | 32 | 2017 |
| Aberrant Ikaros, Aiolos, and Helios expression in Hodgkin and non-Hodgkin lymphoma M Antica, L Cicin-Sain, S Kapitanovic, M Matulic, S Dzebro, M Dominis Blood, The Journal of the American Society of Hematology 111 (6), 3296-3297, 2008 | 31 | 2008 |
| Telomere dynamics: the means to an end M Matulić, M Sopta, I Rubelj Cell proliferation 40 (4), 462-474, 2007 | 27 | 2007 |
| Resistance of human larynx carcinoma cells to cisplatin, γ-irradiation and methotrexate does not involve overexpression of c-myc or c-Ki-ras oncogenes M Osmak, L Beketić-Orešković, M Matulić, J Sorić Mutation Research Letters 303 (3), 113-120, 1993 | 26 | 1993 |
| miRNAs: EBV mechanism for escaping host’s immune response and supporting tumorigenesis S Židovec Lepej, M Matulić, P Gršković, M Pavlica, L Radmanić, P Korać Pathogens 9 (5), 353, 2020 | 23 | 2020 |
| Genetic factors in dilated cardiomyopathy. L Mestroni, J Milasin, M Vatta, B Pinamonti, GF Sinagra, C Rocco, ... Archives des Maladies du Coeur et des Vaisseaux 89, 15-20, 1996 | 18 | 1996 |
| Sodium salicylate inhibits urokinase activity in MDA MB-231 breast cancer cells J Madunić, L Horvat, I Majstorović, I Jodłowska, M Antica, M Matulić Clinical breast cancer 17 (8), 629-637, 2017 | 15 | 2017 |
| Heat stress affects H3K9me3 level at human alpha satellite DNA repeats I Feliciello, A Sermek, Ž Pezer, M Matulić, Đ Ugarković Genes 11 (6), 663, 2020 | 14 | 2020 |
| Molecular mechanisms involved in the antiproliferative action of protein tyrosine phosphatase inhibitor potassium bisperoxo (1, 10-phenanthroline) oxovanadate J Ban, D Maysinger, V Kovač, I Galetić, M Matulić, M Hadžija, B Užarević Life Sciences 68 (2), 165-175, 2000 | 13 | 2000 |
| Site-specific mutagenesis of the histidine precursor of diphthamide in the human elongation factor-2 gene confers resistance to diphtheria toxin M Ivankovic, I Rubelj, M Matulic, E Reich, B Brdar Mutation Research/Genetic Toxicology and Environmental Mutagenesis 609 (1 …, 2006 | 12 | 2006 |
| Globularia alypum L. and Related Species: LC-MS Profiles and Antidiabetic, Antioxidant, Anti-Inflammatory, Antibacterial and Anticancer Potential M Friščić, R Petlevski, I Kosalec, J Madunić, M Matulić, F Bucar, ... Pharmaceuticals 15 (5), 506, 2022 | 11 | 2022 |
| Induction of plasminogen activator by N-methyl-N′-nitro-N-nitrosoguanidine in mer+ and mer− human tumour cell strains B Brdar, M Matulić Carcinogenesis 9 (12), 2191-2195, 1988 | 10 | 1988 |
| Effect of Notch and PARP pathways’ inhibition in leukemic cells L Horvat, M Antica, M Matulić Cells 7 (6), 58, 2018 | 9 | 2018 |
| Evaluation of the cytotoxic activity of Hypericum spp. on human glioblastoma A1235 and breast cancer MDA MB-231 cells J Madunić, M Matulić, M Friščić, KH Pilepić Journal of Environmental Science and Health, Part A 51 (13), 1157-1163, 2016 | 9 | 2016 |
| Notch affects the prodifferentiating effect of retinoic acid and PMA on leukemic cells M Matulic, J Skelin, D Radic‐Kristo, I Kardum‐Skelin, D Grcevic, M Antica Cytometry part a 87 (2), 129-136, 2015 | 9 | 2015 |
| Ikaros family transcription factors in chronic and acute leukemia M Matulic, M Paradzik, L Cicin-Sain, S Kapitanovic, K Dubravcic, D Batinic, ... Am J Hematol 84 (6), 375-377, 2009 | 9 | 2009 |
| miRNA in molecular diagnostics M Matulić, P Gršković, A Petrović, V Begić, S Harabajsa, P Korać Bioengineering 9 (9), 459, 2022 | 8 | 2022 |
| Induction of urokinase-type plasminogen activator by sodium salicylate in a glioblastoma cell strain M Matulić, B Brdar Food technology and biotechnology 39 (1), 5-11, 2001 | 8 | 2001 |
| Modulation of urokinase plasminogen activator system by poly (ADP-ribose) polymerase-1 inhibition J Madunić, M Antica, P Cvjetko, L Požgaj, M Matulić Cytotechnology 68, 783-794, 2016 | 6 | 2016 |
